Table: Garna Biosciences - 9-MTH group results

Carna Biosciences

07/11/2022 06:30

Nov 7 (Reuters)- 
             Garna Biosciences Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to   
                Sep 30, 2022        Sep 30, 2021       Dec 31, 2022  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Sales             1.10               636 mln             1.19      
                 (+72.1 pct)         (-24.9 pct)       (-41.2 pct)   
  Operating     loss 753 mln          loss 1.17         loss 1.67    
  Recurring     loss 735 mln          loss 1.17         loss 1.69    
  Net           loss 795 mln          loss 1.18         loss 1.74    
  EPS          loss 58.56 yen      loss 94.24 yen    loss 128.46 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Garna Biosciences Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T